Ascaphin-8
General Information
DCTPep ID DCTPep02465
Peptide Name Ascaphin-8
Sequence GFKDLLKGAAKALVKTVLF
Sequence Length 19
UniProt ID P0CJ32
PubChem CID 16143925
Origin Ascaphus truei
Type Native peptide
Classification
ACP Tumor active peptide Membrane lysis
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
HepG2 | Hepatoblastoma | LC50=20 µM | CytoTox 96 non-radiactive cytotoxicity assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: LC50=55 µM
Normal (non-cancerous) Cytotoxicity L929 fibroblast-derived cells: LC50=7 µM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep02465
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C97H163N23O23
Absent amino acids CEHIMNPQRSWY
Theoretical pI 10.00
Acidic residues 1
Basic residues 4
Polar residues 3
Molecular weight (Average) 2019.5
Molecular weight (Monoisotopic) 2018.23
Common amino acids KL
Net charge 3
Instability index (II) -13.36
Aliphatic index 128.42
Grand average of hydropathicity (GRAVY) 0.737
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 18554256
Title Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7
Doi 10.1111/j.1747-0285.2008.00671.x
Year 2008
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPR_2300